SomnoMed Ltd

SOM

Company Profile

  • Business description

    SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

  • Contact

    20 Clarke Street
    Level 3
    Crows Nest
    SydneyNSW2065
    AUS

    T: +61 294670400

    https://www.somnomed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    22

Stocks News & Analysis

stocks

Microsoft earnings: Strong, including Azure, but overall guidance is in line

We think Microsoft stock is moderately undervalued.
stocks

After earnings, is Tesla stock a buy, a sell, or fairly valued?

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.
stocks

3 cheap fully franked stocks

Well priced Aussie shares that offer a tax rebate.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,205.001.70-0.02%
CAC 408,157.2943.59-0.53%
DAX 4024,118.895.32-0.02%
Dow JONES (US)47,522.12109.88-0.23%
FTSE 1009,760.063.920.04%
HKSE26,050.08232.61-0.89%
NASDAQ23,581.14377.33-1.57%
Nikkei 22552,211.69886.081.73%
NZX 50 Index13,544.5185.220.63%
S&P 5006,822.3468.25-0.99%
S&P/ASX 2008,909.104.10-0.05%
SSE Composite Index3,961.6225.28-0.63%

Market Movers